Cognitive and Physical Stimulation and Promotion of Social Relations for the Benefit of Older People's Quality of Life

NCT ID: NCT05721508

Last Updated: 2025-03-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

172 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-20

Study Completion Date

2024-12-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this interventional study is thus to assess and highlight the cognitive, physical, and psychosocial benefits of a combined physical and cognitive training program in an enriched environment and to assess the factors influencing these benefits.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The number of older people worldwide is constantly increasing. However, one of the main problems associated with aging is cognitive decline, which affects essential everyday functions such as memory, attention, and executive functions. Thus, maintaining autonomy and quality of life depends on physical health, and the integrity of cognitive functioning. Cognitive, physical and social activities can all slow this decline but social factors and their contribution to the well-being of older people remain under-researched. The aim of the present study is to analyze how the practice environment can foster these social relations and thus enhance wellbeing and to identify the psychological dimensions that are activated by social relations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Individual practice at home

Participants will undergo a training program combining physical and cognitive activities in individual practice at home.

Group Type EXPERIMENTAL

Combined physical and cognitive program

Intervention Type OTHER

All participants will complete 12-week training sessions combining physical and cognitive activities, with two 1-hour sessions per week.

Group practice in a traditional group environment (gymnasium)

Participants will undergo a training program combining physical and cognitive activities in group practice in a traditional group environment (gymnasium).

Group Type EXPERIMENTAL

Combined physical and cognitive program

Intervention Type OTHER

All participants will complete 12-week training sessions combining physical and cognitive activities, with two 1-hour sessions per week.

Group practice in an enriched environment fostering social relations

Participants will undergo a training program combining physical and cognitive activities in group practice in an enriched environment fostering social relations.

Group Type EXPERIMENTAL

Combined physical and cognitive program

Intervention Type OTHER

All participants will complete 12-week training sessions combining physical and cognitive activities, with two 1-hour sessions per week.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Combined physical and cognitive program

All participants will complete 12-week training sessions combining physical and cognitive activities, with two 1-hour sessions per week.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* People must be at least 65 years old
* People must be at independent (able to get around on their own: car, bus, walking)
* People must be at living in the community (not in an institution such as a nursing home)
* The persons recruited must have a score on the Montreal Cognitive Assessment (MoCA) of at least 18.

Exclusion Criteria

* People with contraindications for engaging in regular physical activity
* People with severe neurological and psychological disorders.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Poitiers

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Clarys

Role: STUDY_DIRECTOR

University of Poitiers

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Poitiers

Poitiers, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Gonnord T, Clarys D; StimCoAPS Consortium; Dupuy O, Albouy M, Migeot V, Grangeiro R, Esnard C, Boucard G. Effects of combined physical and cognitive program performed in socially enriched environment on older people's cognitive abilities and quality of life (StimCoAPS): study protocol for a randomized controlled trial. BMJ Open Sport Exerc Med. 2023 Oct 11;9(4):e001577. doi: 10.1136/bmjsem-2023-001577. eCollection 2023.

Reference Type DERIVED
PMID: 37860154 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AAPR2021-2020-12021410

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.